Fertigation Supervisor
CuraleafSalary not specified
- Full Time
- Junior (1 to 2 years), Entry Level & New Grad
About Curaleaf
Curaleaf provides a range of cannabis products for both medical and recreational users. The company grows, processes, and sells various cannabis items, including tinctures, flowers, and edibles. Their products utilize advanced encapsulation technology, which helps improve how well the body absorbs the active ingredients, leading to a better experience for users. Curaleaf stands out from competitors by not only selling products through dispensaries and online but also offering medical consultations to guide customers in their choices. Additionally, the company is committed to social responsibility, exemplified by their B NOBLE program, which supports individuals affected by non-violent cannabis-related charges. The goal of Curaleaf is to provide high-quality cannabis products while promoting awareness and support for social justice issues.
Wakefield, MassachusettsHeadquarters
2010Year Founded
$955MTotal Funding
IPOCompany Stage
Food & Agriculture, Social Impact, HealthcareIndustries
1,001-5,000Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
Parental Leave
401(k) Retirement Plan
Life Insurance
Disability Insurance
Risks
Increased competition as more states legalize adult-use cannabis may impact market share.
Regulatory challenges in hemp-derived THC market could limit product offerings.
Potential financial strain from European expansion may affect short-term profitability.
Differentiation
Curaleaf offers a wide range of cannabis products for medical and recreational use.
The company uses advanced encapsulation technology for enhanced product absorption and efficacy.
Curaleaf's social responsibility initiatives, like B NOBLE, set it apart in the industry.
Upsides
Expansion into adult-use sales in Ohio and New York boosts customer base and sales.
Launch of Select Fruit Stiq caters to demand for discreet, flavorful vaping options.
Entry into European market via EMMAC acquisition positions Curaleaf for international growth.
Funding
Total raised$955.00 M
Latest valuation$4.00 B
StageIPO
POST IPO DEBT
10/31/2024$40
POST IPO EQUITY
11/30/2022$200
IPO
9/30/2018$400
$4.00 B